• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

匙羹藤免疫疗法:阻塞性黄疸治疗的新线索。

Immunotherapy with Tinospora cordifolia: a new lead in the management of obstructive jaundice.

作者信息

Rege N, Bapat R D, Koti R, Desai N K, Dahanukar S

机构信息

Department of Pharmacology, Seth G S Medical College, Bombay.

出版信息

Indian J Gastroenterol. 1993 Jan;12(1):5-8.

PMID:8330924
Abstract

OBJECTIVE

Immunosuppression associated with deranged hepatic function and sepsis results in poor surgical outcome in extrahepatic obstructive jaundice. The effect of an ayurvedic agent, Tinospora cordifolia (TC), which has been shown to have hepatoprotective and immunomodulatory properties in experimental studies, on surgical outcome in patients with malignant obstructive jaundice was evaluated.

METHODS

Thirty patients were randomly divided into two groups, matched with respect to clinical features, impairment of hepatic function (as judged by liver function tests including antipyrine elimination) and immunosuppression (phagocytic and killing capacities of neutrophils). Group I received conventional management, ie vitamin K, antibiotics and biliary drainage; Group II received Tinospora cordifolia (16 mg/kg/day orally) in addition, during the period of biliary drainage.

RESULTS

Hepatic function remained comparable in the two groups after drainage. However, the phagocytic and killing capacities of neutrophils normalized only in patients receiving Tinospora cordifolia (28.2 +/- 5.5% and 29.47 +/- 6.5% respectively). Post-drainage bactobilia was observed in 8 patients in Group I and 7 in Group II, but clinical evidence of septicemia was observed in 50% of patients in Group I as against none in Group II (p < 0.05). Post-operative survival in Groups I and II was 40% and 92.4% respectively (p < 0.01).

CONCLUSION

Tinospora cordifolia appears to improve surgical outcome by strengthening host defenses.

摘要

目的

肝功能紊乱和脓毒症相关的免疫抑制会导致肝外梗阻性黄疸患者手术预后不良。评估一种阿育吠陀药物心叶青牛胆(TC)对恶性梗阻性黄疸患者手术预后的影响,该药物在实验研究中已显示出具有肝脏保护和免疫调节特性。

方法

30例患者随机分为两组,两组在临床特征、肝功能损害(通过包括安替比林消除在内的肝功能检查判断)和免疫抑制(中性粒细胞的吞噬和杀伤能力)方面相匹配。第一组接受常规治疗,即维生素K、抗生素和胆道引流;第二组在胆道引流期间还额外接受心叶青牛胆(口服16mg/kg/天)。

结果

引流后两组肝功能保持相当。然而,仅接受心叶青牛胆治疗的患者中性粒细胞的吞噬和杀伤能力恢复正常(分别为28.2±5.5%和29.47±6.5%)。第一组8例患者和第二组7例患者引流后出现胆血症,但第一组50%的患者出现败血症临床证据,而第二组无(p<0.05)。第一组和第二组术后生存率分别为40%和92.4%(p<0.01)。

结论

心叶青牛胆似乎通过增强宿主防御来改善手术预后。

相似文献

1
Immunotherapy with Tinospora cordifolia: a new lead in the management of obstructive jaundice.匙羹藤免疫疗法:阻塞性黄疸治疗的新线索。
Indian J Gastroenterol. 1993 Jan;12(1):5-8.
2
Can we do away with PTBD?我们能否摒弃经皮经肝胆道引流术(PTBD)?
HPB Surg. 1995;9(1):5-11. doi: 10.1155/1995/90362.
3
Modulation of immunosuppression in obstructive jaundice by Tinospora cordifolia.毛叶锡生藤对梗阻性黄疸免疫抑制的调节作用
Indian J Med Res. 1989 Dec;90:478-83.
4
Immunotherapeutic modification of Escherichia coli peritonitis and bacteremia by Tinospora cordifolia.匙羹藤对大肠杆菌性腹膜炎和菌血症的免疫治疗性修饰
J Postgrad Med. 1992 Jan-Mar;38(1):13-5.
5
Hepatoprotective Activity of Satwa, an Ayurvedic Formulation, Against Alcohol-induced Liver Injury in Rats.印度草医学配方萨特瓦对大鼠酒精性肝损伤的保肝活性
Altern Ther Health Med. 2017 Jul;23(4):34-40.
6
[Hepatoprotective effects of orally administered melatonin and tinospora cordifolia in experimental jaundice].
Chirurgia (Bucur). 2011 Mar-Apr;106(2):205-10.
7
Immunomodulatory active compounds from Tinospora cordifolia.从三叶鬼针草中提取的免疫调节活性化合物。
J Ethnopharmacol. 2012 Jun 14;141(3):918-26. doi: 10.1016/j.jep.2012.03.027. Epub 2012 Mar 26.
8
Comparative immunomodulation potential of Tinospora cordifolia (Willd.) Miers ex Hook. F., Tinospora sinensis (Lour.) Merrill and Tinospora cordifolia growing on Azadirachta indica A. Juss.毛叶锡生藤、中华青牛胆以及生长在印楝上的毛叶锡生藤的比较免疫调节潜力
Indian J Exp Biol. 2014 Aug;52(8):808-13.
9
Validation of ethnomedicinal potential of Tinospora cordifolia for anticancer and immunomodulatory activities and quantification of bioactive molecules by HPTLC.验证印度防己对癌症和免疫调节活性的民族药用潜力,并通过高效薄层色谱法对生物活性分子进行定量分析。
J Ethnopharmacol. 2015 Dec 4;175:131-7. doi: 10.1016/j.jep.2015.08.001. Epub 2015 Aug 5.
10
Hepatoprotective and immunomodulatory properties of Tinospora cordifolia in CCl4 intoxicated mature albino rats.心叶青牛胆对四氯化碳中毒的成年白化大鼠的肝保护和免疫调节特性
J Toxicol Sci. 2002 Aug;27(3):139-46. doi: 10.2131/jts.27.139.

引用本文的文献

1
Biocontrol Agents and Natural Feed Supplements as a Safe and Cost-Effective Way for Preventing Health Ailments Provoked by Mycotoxins.生物防治剂和天然饲料添加剂作为预防霉菌毒素引发健康问题的安全且经济高效的方法。
Foods. 2025 May 31;14(11):1960. doi: 10.3390/foods14111960.
2
Indian herb and species: Phytochemical and therapeutic application.印度草药及物种:植物化学与治疗应用。
Heliyon. 2024 May 16;10(10):e31229. doi: 10.1016/j.heliyon.2024.e31229. eCollection 2024 May 30.
3
Natural feed additives and bioactive supplements versus chemical additives as a safe and practical approach to combat foodborne mycotoxicoses.
天然饲料添加剂和生物活性补充剂与化学添加剂相比,是对抗食源性霉菌毒素中毒的一种安全实用方法。
Front Nutr. 2024 Feb 19;11:1335779. doi: 10.3389/fnut.2024.1335779. eCollection 2024.
4
: An insight on the multifarious pharmacological paradigms of a most promising medicinal ayurvedic herb.对一种最有前景的阿育吠陀药用草本植物多种药理模式的洞察
Heliyon. 2024 Feb 15;10(4):e26125. doi: 10.1016/j.heliyon.2024.e26125. eCollection 2024 Feb 29.
5
Can Guduchi (Tinospora cordifolia), a well-known ayurvedic hepato-protectant cause liver damage?著名的阿育吠陀保肝药匙羹藤(心叶宽筋藤)会导致肝损伤吗?
J Ayurveda Integr Med. 2023 Jan-Feb;14(1):100658. doi: 10.1016/j.jaim.2022.100658. Epub 2022 Nov 16.
6
Efficacy and safety of in asymptomatic and mild-to-moderate cases of coronavirus disease-19: A randomized controlled pilot study.在无症状和轻至中度新型冠状病毒肺炎病例中的疗效和安全性:一项随机对照试验性研究
Ayu. 2020 Jul-Sep;41(3):188-196. doi: 10.4103/ayu.ayu_11_21. Epub 2022 Feb 24.
7
Author Response to Letters on the Manuscript "Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series".作者对关于手稿《新冠疫情期间草药免疫增强剂诱发的肝损伤——病例系列》的信件的回复。
J Clin Exp Hepatol. 2022 Jan-Feb;12(1):260-262. doi: 10.1016/j.jceh.2021.09.020. Epub 2021 Oct 5.
8
Review of health-care services for older population in India and possibility of incorporating AYUSH in public health system for geriatric care.印度老年人口医疗保健服务综述以及将阿育吠陀医学纳入老年保健公共卫生系统的可能性。
Ayu. 2020 Jan-Mar;41(1):3-11. doi: 10.4103/ayu.AYU_172_16. Epub 2021 Jul 30.
9
Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series.新冠疫情期间草药免疫增强剂所致肝损伤——病例系列
J Clin Exp Hepatol. 2021 Nov-Dec;11(6):732-738. doi: 10.1016/j.jceh.2021.06.021. Epub 2021 Jul 2.
10
Phagocytosis, Degranulation and Extracellular Traps Release by Neutrophils-The Current Knowledge, Pharmacological Modulation and Future Prospects.中性粒细胞的吞噬作用、脱颗粒作用和细胞外陷阱释放——当前认知、药理学调控及未来展望
Front Pharmacol. 2021 May 4;12:666732. doi: 10.3389/fphar.2021.666732. eCollection 2021.